Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating roxadustat for anemia in adults with ESRD on stable dialysis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease-associated Anemia
• End-stage Renal Disease with Anemia

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: CKD Anemia in Stable Dialysis Patients | Phase 3 | Status: COMPLETED | Results posted: 2021-10-29